Computed radiography (CR) firm iCRco has received clearance from the U.S. Food and Drug Administration (FDA) for its 3600M mammography system.
iCR3600M weighs 78 lb and can be used in a wall-mounted or tabletop configuration, the firm said. The system can be employed in either centralized or decentralized environments, and it enables breast facilities to move into digital mammography at a lower cost.
The company's True Flat Scan Path technology guarantees 300,000 images per cassette, and the system is paired with phosphor-screen cassettes that have a higher overall detective quantum efficiency (DQE) and resolution than standard CR, according to the firm.
The system is also one of the first product lines from iCRco to use the company's new Crystal IP detectors, which employ needle-shaped crystals positioned side by side, resulting in a greater packing density and more efficient x-ray absorption in the active area. The needle-shaped crystals can achieve higher x-ray absorption at a faster rate, iCRco said.
